Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tetrahydrocannabinol valine hemisuccinate - Skye Bioscience

Next Previous
Drug Profile

Tetrahydrocannabinol valine hemisuccinate - Skye Bioscience

Alternative Names: NB-1111; Sb-100 OE; SBI-100; SBI-100 OE; SBI-100 Ophthalmic Emulsion; THC-VHS-NEC; THCVHS; THCVHS- Skye Bioscience; THCVHS-NE; UM-5050

Latest Information Update: 14 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Mississippi
  • Developer Skye Bioscience
  • Class Antiglaucomas; Cannabinoids; Small molecules
  • Mechanism of Action Cannabinoid receptor CB1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Glaucoma; Ocular hypertension; Open-angle glaucoma

Most Recent Events

  • 10 Jun 2024 Discontinued - Phase-I for Glaucoma (In volunteers) in Australia (Ophthalmic)
  • 10 Jun 2024 Discontinued - Phase-II for Ocular hypertension in USA (Ophthalmic)
  • 10 Jun 2024 Discontinued - Phase-II for Open-angle glaucoma in USA (Ophthalmic)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top